SCHEMBL17845503

SCHEMBL17845503

Cc1nnc(-n2c(=O)n(C(C)C3(C#N)CC3)c3ccc(S(N)(=O)=O)cc32)s1

nearest known ligand 0.52

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 20/20 0.52
ADPRS Q9NX46 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17845415 0.84 PARG (0.54) PARGADPRS
SCHEMBL28524828 0.81 PARG (0.57) PARGADPRS
SCHEMBL28909112 0.77 PARG (0.57) PARGADPRS
SCHEMBL31121958 0.74 PARG (0.58) PARGADPRS
SCHEMBL17845325 0.70 PARG (0.55) PARG
SCHEMBL17845293 0.69 PARG (1.00) PARGADPRS
SCHEMBL31121996 0.68 PARG (0.49) PARGADPRS
SCHEMBL28531505 0.68 PARG (0.49) PARGADPRS
SCHEMBL17845357 0.67 PARG (1.00) PARGADPRS
SCHEMBL17845322 0.66 PARG (1.00) PARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233845-A1 PARG INHIBITORY COMPOUNDS Cancer Research Technology Limited (GB) 2017-10-25 EP disclosed
WO-2016097749-A1 PARG INHIBITORY COMPOUNDS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-23 WO disclosed